Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05403333 · UNKNOWN
Trial details
- NCT number
- NCT05403333
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2023-03-09
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.